Canaccord Genuity Reiterates Buy on CareTrust REIT (CTRE) Following 1Q - PT to $16
Canaccord Genuity reiterated a Buy rating on CareTrust REIT (NASDAQ: CTRE), and raised the price target to $16.00 (from $15.00) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
